| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 51 | 2024 | 3047 | 5.840 |
Why?
|
| Smoke | 18 | 2022 | 227 | 4.640 |
Why?
|
| Respiratory Mucosa | 24 | 2021 | 427 | 4.490 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 18 | 2023 | 1434 | 3.490 |
Why?
|
| Bronchitis, Chronic | 6 | 2023 | 62 | 3.480 |
Why?
|
| Smoking | 35 | 2023 | 8987 | 2.730 |
Why?
|
| Epithelial Cells | 27 | 2023 | 3690 | 2.720 |
Why?
|
| Pulmonary Emphysema | 10 | 2024 | 672 | 2.390 |
Why?
|
| Lung | 47 | 2024 | 9857 | 2.330 |
Why?
|
| Forced Expiratory Volume | 18 | 2023 | 1745 | 2.110 |
Why?
|
| Wood | 8 | 2022 | 89 | 1.830 |
Why?
|
| Mitochondrial Proteins | 8 | 2023 | 994 | 1.680 |
Why?
|
| Emphysema | 3 | 2024 | 247 | 1.640 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2017 | 2917 | 1.640 |
Why?
|
| Hyperplasia | 13 | 2021 | 1185 | 1.520 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2022 | 329 | 1.510 |
Why?
|
| Pneumonia | 10 | 2023 | 2133 | 1.510 |
Why?
|
| Lipopolysaccharides | 15 | 2018 | 2216 | 1.490 |
Why?
|
| Interleukin-13 | 5 | 2018 | 389 | 1.420 |
Why?
|
| Apoptosis Regulatory Proteins | 11 | 2023 | 1157 | 1.390 |
Why?
|
| Sputum | 6 | 2021 | 476 | 1.280 |
Why?
|
| Goblet Cells | 7 | 2016 | 287 | 1.250 |
Why?
|
| Allergens | 13 | 2021 | 1320 | 1.240 |
Why?
|
| Bronchi | 12 | 2021 | 840 | 1.150 |
Why?
|
| Bronchoalveolar Lavage Fluid | 19 | 2018 | 768 | 1.130 |
Why?
|
| Mucus | 8 | 2016 | 321 | 1.050 |
Why?
|
| Health Status | 5 | 2018 | 4034 | 1.030 |
Why?
|
| Influenza A virus | 3 | 2023 | 456 | 1.030 |
Why?
|
| Uteroglobin | 5 | 2018 | 58 | 1.000 |
Why?
|
| Volatile Organic Compounds | 2 | 2022 | 81 | 0.990 |
Why?
|
| Metaplasia | 14 | 2016 | 313 | 0.990 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 2949 | 0.980 |
Why?
|
| Interferon-gamma | 10 | 2018 | 3207 | 0.970 |
Why?
|
| Orthomyxoviridae Infections | 3 | 2016 | 248 | 0.960 |
Why?
|
| Hexosyltransferases | 1 | 2023 | 53 | 0.950 |
Why?
|
| Spirometry | 6 | 2023 | 865 | 0.940 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2008 | 295 | 0.940 |
Why?
|
| Apoptosis | 21 | 2023 | 9724 | 0.910 |
Why?
|
| Mucin 5AC | 6 | 2018 | 93 | 0.850 |
Why?
|
| Autophagy | 4 | 2013 | 1297 | 0.850 |
Why?
|
| Casein Kinase II | 1 | 2021 | 128 | 0.780 |
Why?
|
| Asthma | 15 | 2022 | 6010 | 0.760 |
Why?
|
| Airway Remodeling | 3 | 2018 | 132 | 0.750 |
Why?
|
| Pyroglyphidae | 2 | 2018 | 88 | 0.730 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 139 | 0.700 |
Why?
|
| Vital Capacity | 6 | 2023 | 925 | 0.700 |
Why?
|
| Mice, Inbred C57BL | 26 | 2024 | 21833 | 0.690 |
Why?
|
| Air Pollutants | 6 | 2022 | 2816 | 0.690 |
Why?
|
| Genes, bcl-2 | 4 | 2011 | 122 | 0.680 |
Why?
|
| Mucins | 5 | 2022 | 564 | 0.680 |
Why?
|
| Hypersensitivity | 3 | 2018 | 1102 | 0.670 |
Why?
|
| Inflammation | 15 | 2023 | 10637 | 0.670 |
Why?
|
| Animals | 81 | 2024 | 168768 | 0.650 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2023 | 1335 | 0.640 |
Why?
|
| New Mexico | 7 | 2018 | 86 | 0.640 |
Why?
|
| DNA Methylation | 9 | 2020 | 4285 | 0.630 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 69 | 0.620 |
Why?
|
| Rats, Inbred F344 | 10 | 2016 | 862 | 0.620 |
Why?
|
| Interleukin-9 | 2 | 2008 | 63 | 0.610 |
Why?
|
| Mucous Membrane | 5 | 2011 | 673 | 0.610 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2017 | 75 | 0.610 |
Why?
|
| Endoplasmic Reticulum | 2 | 2017 | 1146 | 0.590 |
Why?
|
| Gene Expression | 9 | 2022 | 7798 | 0.580 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2016 | 165 | 0.580 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2019 | 638 | 0.570 |
Why?
|
| Membrane Proteins | 9 | 2020 | 7882 | 0.570 |
Why?
|
| Nasal Septum | 1 | 2018 | 127 | 0.570 |
Why?
|
| Poly I-C | 1 | 2016 | 115 | 0.550 |
Why?
|
| GATA4 Transcription Factor | 2 | 2014 | 131 | 0.540 |
Why?
|
| Mice | 48 | 2024 | 81201 | 0.540 |
Why?
|
| Ovalbumin | 9 | 2017 | 719 | 0.540 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1988 | 0.530 |
Why?
|
| Lysosomes | 1 | 2020 | 893 | 0.520 |
Why?
|
| Caspase 3 | 3 | 2016 | 758 | 0.520 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2016 | 480 | 0.500 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2016 | 489 | 0.490 |
Why?
|
| Cough | 1 | 2018 | 555 | 0.490 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 2016 | 0.480 |
Why?
|
| Anoikis | 1 | 2013 | 49 | 0.470 |
Why?
|
| Cell Death | 5 | 2016 | 1707 | 0.460 |
Why?
|
| Weight Gain | 2 | 2014 | 2293 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2014 | 318 | 0.460 |
Why?
|
| Immunity, Mucosal | 1 | 2016 | 490 | 0.450 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2021 | 816 | 0.440 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2015 | 209 | 0.440 |
Why?
|
| Proteomics | 3 | 2023 | 3638 | 0.430 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2012 | 0.430 |
Why?
|
| Cytokines | 11 | 2023 | 7323 | 0.420 |
Why?
|
| Genes, p53 | 1 | 2014 | 755 | 0.420 |
Why?
|
| Interleukin-17 | 1 | 2018 | 901 | 0.410 |
Why?
|
| ADAM Proteins | 3 | 2020 | 243 | 0.410 |
Why?
|
| Particulate Matter | 2 | 2022 | 2529 | 0.400 |
Why?
|
| Rolipram | 1 | 2011 | 27 | 0.400 |
Why?
|
| Humans | 106 | 2023 | 744366 | 0.400 |
Why?
|
| Neutrophil Infiltration | 3 | 2016 | 391 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 7 | 2015 | 5867 | 0.380 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3486 | 0.380 |
Why?
|
| Homeostasis | 2 | 2020 | 3339 | 0.380 |
Why?
|
| Mice, Knockout | 16 | 2020 | 14561 | 0.370 |
Why?
|
| Neutrophils | 8 | 2019 | 3721 | 0.360 |
Why?
|
| Immunologic Memory | 1 | 2016 | 1348 | 0.350 |
Why?
|
| Influenza, Human | 2 | 2023 | 1479 | 0.350 |
Why?
|
| RNA | 1 | 2020 | 2749 | 0.350 |
Why?
|
| Male | 66 | 2023 | 350115 | 0.350 |
Why?
|
| Activities of Daily Living | 2 | 2016 | 2419 | 0.340 |
Why?
|
| Lung Neoplasms | 8 | 2020 | 13104 | 0.340 |
Why?
|
| Pneumonia, Viral | 2 | 2018 | 3242 | 0.340 |
Why?
|
| Viral Proteins | 1 | 2016 | 1900 | 0.330 |
Why?
|
| Disease Models, Animal | 15 | 2024 | 18034 | 0.330 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 92 | 0.320 |
Why?
|
| Macrophages, Alveolar | 6 | 2020 | 407 | 0.320 |
Why?
|
| STAT1 Transcription Factor | 2 | 2007 | 320 | 0.320 |
Why?
|
| Interleukin-18 | 2 | 2007 | 249 | 0.320 |
Why?
|
| Mitochondria | 2 | 2020 | 3514 | 0.320 |
Why?
|
| Rats | 17 | 2018 | 24252 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 12073 | 0.300 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1516 | 0.290 |
Why?
|
| Trachea | 4 | 2017 | 1076 | 0.290 |
Why?
|
| Quality of Life | 3 | 2022 | 12802 | 0.290 |
Why?
|
| Matrix Metalloproteinase 8 | 2 | 2019 | 56 | 0.290 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2006 | 4554 | 0.290 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2005 | 274 | 0.280 |
Why?
|
| Female | 57 | 2023 | 380193 | 0.270 |
Why?
|
| Horse Diseases | 1 | 2006 | 57 | 0.270 |
Why?
|
| Middle Aged | 37 | 2023 | 213390 | 0.260 |
Why?
|
| RNA, Messenger | 6 | 2021 | 13035 | 0.260 |
Why?
|
| Lung Diseases | 2 | 2014 | 1887 | 0.260 |
Why?
|
| Cell Division | 5 | 2021 | 4569 | 0.260 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1796 | 0.260 |
Why?
|
| Inflammation Mediators | 5 | 2016 | 1888 | 0.250 |
Why?
|
| Carbon Monoxide | 3 | 2022 | 531 | 0.250 |
Why?
|
| Organ Culture Techniques | 3 | 2018 | 813 | 0.250 |
Why?
|
| Respiratory Mechanics | 1 | 2008 | 686 | 0.250 |
Why?
|
| Cells, Cultured | 10 | 2020 | 19233 | 0.240 |
Why?
|
| Bronchial Hyperreactivity | 4 | 2013 | 319 | 0.240 |
Why?
|
| Rats, Inbred BN | 5 | 2008 | 235 | 0.240 |
Why?
|
| Calcium | 1 | 2017 | 5755 | 0.240 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2016 | 49 | 0.230 |
Why?
|
| Cell Nucleus | 2 | 2013 | 2969 | 0.230 |
Why?
|
| Aged | 31 | 2021 | 163288 | 0.230 |
Why?
|
| Inhalation Exposure | 6 | 2018 | 443 | 0.220 |
Why?
|
| Sugar Alcohols | 1 | 2022 | 18 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2019 | 15520 | 0.220 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 433 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1790 | 0.210 |
Why?
|
| Respiratory Function Tests | 6 | 2015 | 1617 | 0.210 |
Why?
|
| Pulmonary Alveoli | 4 | 2021 | 675 | 0.210 |
Why?
|
| Exocrine Glands | 1 | 2002 | 50 | 0.210 |
Why?
|
| Nasal Mucosa | 1 | 2004 | 373 | 0.200 |
Why?
|
| Environmental Exposure | 3 | 2018 | 4232 | 0.200 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 12244 | 0.200 |
Why?
|
| Obesity | 2 | 2014 | 12746 | 0.200 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2019 | 141 | 0.200 |
Why?
|
| Risk Factors | 17 | 2022 | 72296 | 0.200 |
Why?
|
| Cell Count | 4 | 2015 | 1856 | 0.200 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2015 | 419 | 0.200 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 25039 | 0.200 |
Why?
|
| Genome-Wide Association Study | 9 | 2023 | 12262 | 0.190 |
Why?
|
| Cystic Fibrosis | 2 | 2012 | 1178 | 0.190 |
Why?
|
| Airway Obstruction | 1 | 2006 | 664 | 0.190 |
Why?
|
| Antiporters | 1 | 2022 | 277 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 156 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2022 | 394 | 0.180 |
Why?
|
| Adult | 28 | 2022 | 214052 | 0.180 |
Why?
|
| Air Pollution | 2 | 2005 | 2286 | 0.180 |
Why?
|
| Disease Progression | 6 | 2021 | 13286 | 0.180 |
Why?
|
| Chemokines | 3 | 2015 | 970 | 0.170 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10183 | 0.170 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2019 | 149 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2020 | 159 | 0.160 |
Why?
|
| Time Factors | 7 | 2016 | 40075 | 0.160 |
Why?
|
| Logistic Models | 5 | 2018 | 13409 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2020 | 437 | 0.160 |
Why?
|
| Pancreatic Elastase | 1 | 2018 | 136 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 8432 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 498 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2019 | 17446 | 0.150 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 100 | 0.150 |
Why?
|
| Gases | 1 | 2018 | 197 | 0.150 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15535 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2016 | 3702 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 96 | 0.140 |
Why?
|
| Species Specificity | 2 | 2015 | 2478 | 0.140 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 964 | 0.140 |
Why?
|
| Endophenotypes | 1 | 2018 | 250 | 0.140 |
Why?
|
| NF-kappa B | 4 | 2023 | 2499 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 530 | 0.140 |
Why?
|
| Virus Replication | 3 | 2023 | 2535 | 0.140 |
Why?
|
| Gene Silencing | 2 | 2013 | 1539 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 436 | 0.130 |
Why?
|
| Markov Chains | 2 | 2016 | 969 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2018 | 1012 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2018 | 4026 | 0.130 |
Why?
|
| Aerosols | 3 | 2011 | 625 | 0.130 |
Why?
|
| Cohort Studies | 9 | 2019 | 40559 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 587 | 0.130 |
Why?
|
| Comorbidity | 3 | 2018 | 10388 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 5953 | 0.130 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2015 | 109 | 0.130 |
Why?
|
| Mice, Nude | 2 | 2016 | 3689 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3646 | 0.120 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2014 | 37 | 0.120 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2014 | 56 | 0.120 |
Why?
|
| Endothelium | 1 | 2017 | 778 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 546 | 0.120 |
Why?
|
| Metformin | 1 | 2021 | 836 | 0.120 |
Why?
|
| Chick Embryo | 1 | 2016 | 982 | 0.120 |
Why?
|
| Dyspnea | 1 | 2022 | 1303 | 0.120 |
Why?
|
| Case-Control Studies | 8 | 2020 | 21748 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 10943 | 0.120 |
Why?
|
| Phenotype | 8 | 2019 | 16367 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 373 | 0.110 |
Why?
|
| Butyric Acid | 1 | 2013 | 55 | 0.110 |
Why?
|
| Th2 Cells | 3 | 2008 | 1061 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1881 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2013 | 789 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 2016 | 381 | 0.110 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 1865 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 582 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 675 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 142 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 565 | 0.110 |
Why?
|
| Bezafibrate | 2 | 2003 | 14 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 1085 | 0.110 |
Why?
|
| Matrix Metalloproteinases | 1 | 2015 | 391 | 0.110 |
Why?
|
| Interleukin-6 | 2 | 2002 | 3203 | 0.110 |
Why?
|
| Health Status Indicators | 2 | 2018 | 970 | 0.110 |
Why?
|
| Sarin | 2 | 2002 | 7 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2017 | 986 | 0.110 |
Why?
|
| Histone Deacetylase 1 | 1 | 2013 | 137 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 612 | 0.110 |
Why?
|
| Dogs | 2 | 2016 | 3912 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 386 | 0.100 |
Why?
|
| Lipoxins | 1 | 2015 | 412 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 722 | 0.100 |
Why?
|
| Dinoprostone | 1 | 2015 | 601 | 0.100 |
Why?
|
| Chemical Warfare Agents | 2 | 2002 | 21 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6364 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3921 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 714 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2015 | 306 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4751 | 0.100 |
Why?
|
| Government Regulation | 1 | 2016 | 522 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 627 | 0.100 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2011 | 61 | 0.100 |
Why?
|
| Signal Transduction | 7 | 2020 | 23404 | 0.100 |
Why?
|
| Macaca fascicularis | 3 | 2021 | 915 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2016 | 1536 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4479 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2014 | 690 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2022 | 9849 | 0.100 |
Why?
|
| Metabolomics | 1 | 2019 | 1485 | 0.100 |
Why?
|
| Genetic Loci | 2 | 2019 | 2575 | 0.100 |
Why?
|
| Proteins | 2 | 2003 | 6100 | 0.100 |
Why?
|
| Alcian Blue | 2 | 2007 | 13 | 0.090 |
Why?
|
| Periodic Acid-Schiff Reaction | 2 | 2007 | 15 | 0.090 |
Why?
|
| Haplotypes | 4 | 2015 | 2779 | 0.090 |
Why?
|
| Air Pollution, Indoor | 1 | 2018 | 857 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2016 | 2617 | 0.090 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16690 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 355 | 0.090 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2009 | 46 | 0.090 |
Why?
|
| Acetylation | 1 | 2013 | 1084 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 494 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3508 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2715 | 0.090 |
Why?
|
| Genotype | 5 | 2015 | 12952 | 0.090 |
Why?
|
| Genes, p16 | 1 | 2010 | 157 | 0.090 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2009 | 91 | 0.090 |
Why?
|
| Carcinogens | 2 | 2003 | 466 | 0.090 |
Why?
|
| Cilia | 1 | 2013 | 466 | 0.090 |
Why?
|
| Horses | 2 | 2011 | 304 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2015 | 2585 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2182 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2019 | 3749 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2011 | 5181 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2017 | 1609 | 0.080 |
Why?
|
| Cathepsin D | 1 | 2008 | 61 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 728 | 0.080 |
Why?
|
| RNA, Catalytic | 1 | 2008 | 50 | 0.080 |
Why?
|
| Cathepsin B | 1 | 2008 | 82 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5856 | 0.080 |
Why?
|
| Annexin A5 | 1 | 2008 | 103 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 349 | 0.080 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 451 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2015 | 961 | 0.080 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2008 | 49 | 0.080 |
Why?
|
| Nicotine | 2 | 2016 | 681 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1801 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2897 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 547 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 13991 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3567 | 0.080 |
Why?
|
| Cell Survival | 3 | 2019 | 5882 | 0.080 |
Why?
|
| Hematoxylin | 1 | 2007 | 64 | 0.080 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2007 | 72 | 0.080 |
Why?
|
| Protein Transport | 2 | 2019 | 1988 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2014 | 9145 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2011 | 2634 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1940 | 0.080 |
Why?
|
| Genetics, Population | 1 | 2013 | 934 | 0.080 |
Why?
|
| Hemagglutinins | 1 | 2007 | 117 | 0.070 |
Why?
|
| Prevalence | 2 | 2022 | 15221 | 0.070 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 1480 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2008 | 197 | 0.070 |
Why?
|
| DNA Damage | 2 | 2014 | 2432 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 197 | 0.070 |
Why?
|
| Mortality | 1 | 2018 | 2864 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 4463 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 180 | 0.070 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2006 | 14 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 972 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9735 | 0.070 |
Why?
|
| Southwestern United States | 1 | 2006 | 37 | 0.070 |
Why?
|
| Eosinophils | 3 | 2013 | 955 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1741 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2022 | 12207 | 0.070 |
Why?
|
| Age Distribution | 1 | 2011 | 2902 | 0.070 |
Why?
|
| Overweight | 1 | 2016 | 2371 | 0.060 |
Why?
|
| Peptides | 1 | 2017 | 4410 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2016 | 8436 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2010 | 810 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2007 | 566 | 0.060 |
Why?
|
| Pedigree | 1 | 2013 | 4642 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15078 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 343 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2725 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.060 |
Why?
|
| Fever | 2 | 2002 | 1616 | 0.060 |
Why?
|
| Autopsy | 1 | 2008 | 1020 | 0.060 |
Why?
|
| Models, Biological | 2 | 2013 | 9584 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2602 | 0.060 |
Why?
|
| Macrophages | 2 | 2016 | 5660 | 0.060 |
Why?
|
| Cell Line | 2 | 2016 | 16000 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2016 | 4222 | 0.060 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2003 | 10 | 0.060 |
Why?
|
| Oxidative Stress | 4 | 2017 | 3084 | 0.060 |
Why?
|
| Base Sequence | 2 | 2006 | 12797 | 0.060 |
Why?
|
| Beryllium | 1 | 2003 | 13 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2006 | 468 | 0.060 |
Why?
|
| Nitrosamines | 1 | 2003 | 87 | 0.060 |
Why?
|
| Antioxidants | 1 | 2011 | 1659 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2007 | 1101 | 0.060 |
Why?
|
| Ploidies | 1 | 2003 | 281 | 0.060 |
Why?
|
| Costa Rica | 2 | 2014 | 177 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 2002 | 29 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2007 | 1460 | 0.050 |
Why?
|
| Body Weight | 3 | 2002 | 4671 | 0.050 |
Why?
|
| Hypoxanthines | 1 | 2021 | 35 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10259 | 0.050 |
Why?
|
| United States | 5 | 2023 | 69872 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 554 | 0.050 |
Why?
|
| Gene Frequency | 3 | 2015 | 3587 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 580 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2005 | 1147 | 0.050 |
Why?
|
| Body Temperature | 2 | 2002 | 777 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2002 | 129 | 0.050 |
Why?
|
| Acute Disease | 1 | 2012 | 7147 | 0.050 |
Why?
|
| Papio papio | 1 | 2021 | 3 | 0.050 |
Why?
|
| Benzo(a)pyrene | 1 | 2001 | 26 | 0.050 |
Why?
|
| Diet | 2 | 2017 | 7937 | 0.050 |
Why?
|
| Leukocyte Count | 2 | 2004 | 1588 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7184 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 9445 | 0.050 |
Why?
|
| Pigmentation | 1 | 2002 | 148 | 0.050 |
Why?
|
| Hydrocarbons | 1 | 2002 | 106 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2006 | 1057 | 0.050 |
Why?
|
| Persian Gulf Syndrome | 1 | 2001 | 45 | 0.050 |
Why?
|
| Eosinophilia | 2 | 2002 | 541 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2016 | 10483 | 0.050 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2021 | 181 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 238 | 0.050 |
Why?
|
| Dissection | 1 | 2002 | 295 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 959 | 0.050 |
Why?
|
| Bronchitis | 1 | 2001 | 200 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 18373 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 1828 | 0.050 |
Why?
|
| CHO Cells | 1 | 2003 | 1409 | 0.050 |
Why?
|
| Receptors, Cholinergic | 1 | 2001 | 238 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2010 | 6459 | 0.050 |
Why?
|
| Incidence | 1 | 2018 | 20952 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2002 | 411 | 0.050 |
Why?
|
| Retinoids | 1 | 2000 | 101 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2001 | 434 | 0.050 |
Why?
|
| P-Selectin | 1 | 2002 | 601 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2017 | 12721 | 0.040 |
Why?
|
| Infant | 1 | 2022 | 35134 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2646 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2000 | 232 | 0.040 |
Why?
|
| Protein Binding | 1 | 2012 | 9384 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 1917 | 0.040 |
Why?
|
| Cricetinae | 1 | 2003 | 2475 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2504 | 0.040 |
Why?
|
| Endotoxins | 1 | 2002 | 527 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2003 | 1472 | 0.040 |
Why?
|
| Probability | 1 | 2004 | 2506 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 1000 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2725 | 0.040 |
Why?
|
| DNA Primers | 1 | 2003 | 2891 | 0.040 |
Why?
|
| Ozone | 1 | 2002 | 469 | 0.040 |
Why?
|
| Software | 1 | 2013 | 4441 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2003 | 604 | 0.040 |
Why?
|
| Lymphocyte Depletion | 1 | 2020 | 608 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2000 | 625 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2001 | 553 | 0.040 |
Why?
|
| Household Products | 1 | 2018 | 26 | 0.040 |
Why?
|
| Respiratory System | 1 | 2021 | 557 | 0.040 |
Why?
|
| Particle Size | 1 | 2002 | 1642 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2011 | 11486 | 0.040 |
Why?
|
| Reference Values | 1 | 2004 | 4982 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2001 | 703 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2001 | 805 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39052 | 0.040 |
Why?
|
| Carbon | 1 | 2001 | 687 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 6386 | 0.040 |
Why?
|
| Larynx | 1 | 2002 | 494 | 0.040 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2016 | 90 | 0.040 |
Why?
|
| Sex Factors | 1 | 2010 | 10400 | 0.030 |
Why?
|
| Animal Experimentation | 1 | 2016 | 45 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2016 | 67 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2001 | 665 | 0.030 |
Why?
|
| Mecamylamine | 1 | 2015 | 29 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 1073 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 574 | 0.030 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2015 | 46 | 0.030 |
Why?
|
| Cooking | 1 | 2018 | 313 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2019 | 538 | 0.030 |
Why?
|
| Spleen | 1 | 2001 | 2362 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2726 | 0.030 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2015 | 31 | 0.030 |
Why?
|
| Transfection | 1 | 2003 | 5895 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20130 | 0.030 |
Why?
|
| Heterozygote | 1 | 2001 | 2804 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2015 | 3001 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4328 | 0.030 |
Why?
|
| Eating | 1 | 2001 | 1536 | 0.030 |
Why?
|
| Fibrinolysin | 1 | 2014 | 131 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6476 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2014 | 97 | 0.030 |
Why?
|
| Recurrence | 1 | 2006 | 8340 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2019 | 53290 | 0.030 |
Why?
|
| Keratins | 1 | 2015 | 515 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2001 | 1186 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11366 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 418 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 705 | 0.030 |
Why?
|
| Phenylbutyrates | 1 | 2013 | 69 | 0.030 |
Why?
|
| Equipment Design | 1 | 2002 | 3582 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 4424 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29060 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4208 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.030 |
Why?
|
| Aldehydes | 1 | 2013 | 167 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6933 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2926 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2001 | 2108 | 0.030 |
Why?
|
| DNA Ligases | 1 | 2011 | 80 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 963 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18111 | 0.020 |
Why?
|
| Gelatinases | 1 | 2011 | 94 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2011 | 158 | 0.020 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 176 | 0.020 |
Why?
|
| Motor Activity | 1 | 2001 | 2715 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2076 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2110 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 379 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2003 | 2408 | 0.020 |
Why?
|
| Cell Movement | 1 | 2003 | 5218 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3338 | 0.020 |
Why?
|
| Drug Design | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 901 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11525 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 365 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14723 | 0.020 |
Why?
|
| Nasal Obstruction | 1 | 2011 | 151 | 0.020 |
Why?
|
| DNA | 1 | 2003 | 7294 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 472 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 909 | 0.020 |
Why?
|
| Azacitidine | 1 | 2011 | 347 | 0.020 |
Why?
|
| Immunoglobulin E | 2 | 2008 | 1463 | 0.020 |
Why?
|
| Biomedical Research | 2 | 2017 | 3309 | 0.020 |
Why?
|
| Ambrosia | 1 | 2008 | 6 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7721 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.020 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2008 | 34 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1584 | 0.020 |
Why?
|
| Leukotriene C4 | 1 | 2008 | 97 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 19905 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2008 | 195 | 0.020 |
Why?
|
| Child | 4 | 2020 | 77709 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 1997 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 1692 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13693 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2001 | 4043 | 0.020 |
Why?
|
| Leukocytes | 1 | 2014 | 2045 | 0.020 |
Why?
|
| Fruit | 1 | 2011 | 1142 | 0.020 |
Why?
|
| Vegetables | 1 | 2011 | 1182 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10252 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2038 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
| Benzamides | 1 | 2011 | 1379 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 55 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 9647 | 0.020 |
Why?
|
| International Cooperation | 1 | 2011 | 1420 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3505 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 8319 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2004 | 253 | 0.010 |
Why?
|
| Bronchiolitis, Viral | 1 | 2004 | 74 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2003 | 50 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2003 | 42 | 0.010 |
Why?
|
| Aging | 1 | 2022 | 8664 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 315 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 4561 | 0.010 |
Why?
|
| Turpentine | 1 | 2002 | 11 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3554 | 0.010 |
Why?
|
| Acetylcholinesterase | 1 | 2002 | 153 | 0.010 |
Why?
|
| Risk | 1 | 2015 | 9688 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2004 | 758 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2002 | 156 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2001 | 77 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2001 | 115 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2001 | 227 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2001 | 233 | 0.010 |
Why?
|
| Solvents | 1 | 2002 | 302 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 226 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2001 | 380 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 719 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6539 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3519 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 397 | 0.010 |
Why?
|
| Autoradiography | 1 | 2001 | 745 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63107 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2001 | 404 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 2001 | 221 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2000 | 194 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2001 | 446 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4420 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 85779 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2890 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2825 | 0.010 |
Why?
|
| Pregnancy | 2 | 2015 | 29144 | 0.010 |
Why?
|
| Young Adult | 2 | 2015 | 56429 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1263 | 0.010 |
Why?
|
| Peroxidase | 1 | 2001 | 611 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 77460 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2006 | 2740 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2020 | 41005 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2327 | 0.010 |
Why?
|
| Immunization | 1 | 2001 | 1256 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1880 | 0.010 |
Why?
|
| Immune System | 1 | 2001 | 806 | 0.010 |
Why?
|
| Viral Load | 1 | 2004 | 3300 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 2173 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 5172 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6313 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 13882 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3799 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 5524 | 0.010 |
Why?
|
| Liver | 1 | 2002 | 7475 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 2000 | 2736 | 0.000 |
Why?
|
| Brain | 2 | 2002 | 26388 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4034 | 0.000 |
Why?
|